US FDA Drug Registration: Step-by-Step FDA Registration & Drug Listing Guide

Us fda drug register search, Us fda drug register pdf, Us fda drug register list, Us fda drug register online, Us fda drug register lookup, US FDA registration number search, FDA Drug database download, FDA drug establishment registration, How to check US FDA registration?, What is FDA registration in the USA?, How do I check if a drug is FDA approved?, How to check if a product is registered in FDA?, What is a 7 digit FDA product code?, How to check if a product is registered?, What is FDA called in India?, What are the 8 types of products regulated by the FDA?, What is the FDA drug number?

Entering the United States pharmaceutical market requires strict regulatory compliance. US FDA Drug Registration is a mandatory process regulated by the U.S. Food and Drug Administration (FDA) for companies involved in manufacturing, processing, or distributing drug products in the US.

Without proper FDA registration and drug listing, drug products may be denied entry into the United States, delayed at ports, or subject to enforcement action.

Understanding US FDA Drug Registration

US FDA Drug Registration is a legal requirement under the Federal Food, Drug, and Cosmetic Act (FD&C Act). It allows the FDA to identify:

Drug manufacturing and processing facilities
Drug products marketed in the United States

The registration framework consists of two mandatory obligations:

Drug Establishment Registration
FDA Drug Product Listing

Both components must be completed and actively maintained for continued compliance.

It is important to clarify that FDA registration is not FDA approval. Registration is a regulatory notification requirement, while FDA approval applies only to certain drugs through separate review pathways.

Who Must Register Drugs with the FDA?

FDA drug registration applies to a wide range of pharmaceutical entities, including:

Prescription drug manufacturers
Over-the-counter (OTC) drug manufacturers
Contract manufacturing organizations (CMOs)
Repackers and relabelers
Foreign drug manufacturers exporting to the US

Foreign companies are additionally required to appoint a US Agent, who serves as the FDA’s official contact for inspections and regulatory communications.

FDA Drug Establishment Registration Requirements

Each physical facility involved in manufacturing, processing, packaging, or labeling drugs must be registered separately with the FDA.

Key Registration Rules

Registration is mandatory and renewed annually
Registration period: October 1 to December 31
Applies to both US-based and foreign facilities
Required before commercial distribution or importation

Failure to renew establishment registration can result in inactive status, shipment delays, or refusal of entry at US ports.

FDA Drug Listing Process Explained

Once establishment registration is completed, every drug product intended for the US market must be listed with the FDA.

Drug listing submissions include detailed product information such as:

Drug name (brand and generic)
Dosage form and strength
Route of administration
Labeler and manufacturer details
National Drug Code (NDC)
Product labeling data

All listings are submitted electronically using Structured Product Labeling (SPL) format. Accuracy and consistency between SPL data and product labels are critical to avoid FDA correction requests.

National Drug Code (NDC) and Its Role

The National Drug Code (NDC) is a unique identifier associated with drug products listed with the FDA. Although the FDA does not approve NDC numbers, correct configuration is essential for:

US commercial distribution
Pharmacy and hospital systems
Insurance reimbursement processes
Import and export documentation

Incorrect NDC setup is a frequent cause of FDA drug listing delays.

FDA Registration for Foreign Drug Manufacturers

Foreign manufacturers face additional compliance requirements, including:

Appointment and maintenance of a US Agent
FDA inspection readiness outside the US
Import compliance coordination
Alignment between listing data and shipping documentation

Any mismatch in registration or listing information may trigger import alerts or shipment holds.

Common FDA Drug Registration Challenges

Many companies experience regulatory issues due to:

Incorrect SPL file preparation
Labeling inconsistencies
Missed annual renewals
Improper US Agent designation
Confusion between registration and approval

These errors can delay product launches and disrupt supply chains.

Why Work with an FDA Drug Registration Consultant?

FDA drug registration requires regulatory expertise, technical accuracy, and ongoing compliance management. Even small mistakes can result in costly delays or regulatory action.

XPRO America, a US FDA Consultancy, provides end-to-end FDA drug registration and listing services for pharmaceutical companies worldwide. Services include establishment registration, drug listing submissions, SPL preparation, NDC configuration, US Agent services, and annual renewal management.

Companies seeking reliable FDA compliance support can reach the regulatory team by emailing support@xproamerica.com for tailored guidance based on product type and market strategy.

Conclusion

US FDA Drug Registration is a foundational requirement for accessing and maintaining presence in the US pharmaceutical market. While procedural, it demands precision, regulatory understanding, and continuous maintenance.

By ensuring accurate FDA establishment registration and drug listing—and partnering with an experienced US FDA consultancy—companies can reduce compliance risks, avoid regulatory delays, and focus on long-term growth in the United States.